$1.79
▲ +$0.00
(+0.00%)
Vol 5.0M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$421.6M
ROE
-491.2%
Margin
-1192.2%
D/E
803.85
Beta
3.56
52W
$1–$2
Wall Street Consensus
13 analysts · Apr 20263
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
92.3%
Buy Rating
Price Chart
Similar Stocks
GYRE
Gyre Therapeutics Inc
P/E 96.5
$641.7M
PURR
Hyperliquid Strategies Inc
ALLO
Allogene Therapeutics Inc
$307.9M
PRME
Prime Medicine Inc
$626.4M
MDXG
MiMedx Group Inc
P/E 24.6
$1.0B
IRWD
Ironwood Pharmaceuticals Inc
P/E 19.2
$548.2M
PROK
Prokidney Corp
$673.9M
TECX
Tectonic Therapeutic Inc
$390.4M
KYTX
Kyverna Therapeutics Inc
$537.0M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.06 | $-0.06 | $0.00 |
| Sep 2025 | $-0.06 | $-0.07 | $-0.01 |
| Jun 2025 | $-0.06 | $-0.05 | +$0.01 |
| Mar 2025 | $-0.06 | $-0.05 | +$0.01 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -255.3% | -255.3% | -255.3% | -255.3% | -491.2% | -491.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1073.5% | -1197.7% | -1197.7% | -1197.7% | -1192.2% | -1192.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 918.25 | 918.25 | 918.25 | 918.25 | 803.85 | 803.85 |
| Current Ratio | 1.83 | 1.83 | 1.83 | 1.83 | 1.85 | 1.85 |
Key Ratios
ROA (TTM)
-99.2%
P/S (TTM)
78.52
P/B
7.9
EPS (TTM)
$-0.22
CF/Share
$-0.32
Rev Growth 3Y
+366.3%
52W High
$1.90
52W Low
$0.52
$0.52
52-Week Range
$1.90
How does OCGN compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
OCGN valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
78.5
▲
511%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
7.9
▲
222%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
OCGN profitability vs Biotechnology peers
ROE
-491.2%
▼
630%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-1192.2%
▼
316%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-99.2%
▼
112%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
OCGN financial health vs Biotechnology peers
D/E ratio
803.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.9
▼
58%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
3.6
▲
267%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
OCGN fundamentals radar
OCGN
Peer median
Industry
OCGN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio